Good Rx Holdings, Inc. GDRX
We take great care to ensure that the data presented and summarized in this overview for GoodRx Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GDRX
View all-
Francisco Partners Management, LP San Francisco, CA70.1MShares$573 Million46.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$66.2 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN7.44MShares$60.8 Million0.01% of portfolio
-
Silver Lake Group, L.L.C. Menlo Park, CA3.53MShares$28.9 Million0.3% of portfolio
-
Lakewood Capital Management, LP New York, NY3.31MShares$27 Million1.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$25.1 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.99MShares$24.4 Million0.01% of portfolio
-
Petrus Trust Company, Lta Dallas, TX2.3MShares$18.8 Million1.57% of portfolio
-
Rubric Capital Management LP New York, NY2.12MShares$17.3 Million0.51% of portfolio
-
Rip Road Capital Partners LP Boston, MA2.06MShares$16.9 Million15.0% of portfolio
Latest Institutional Activity in GDRX
Top Purchases
Top Sells
About GDRX
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
Insider Transactions at GDRX
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 10
2024
|
Trevor Bezdek Chairman |
BUY
Bona fide gift
|
Indirect |
5,265,442
+50.0%
|
-
|
Jun 10
2024
|
Trevor Bezdek Chairman |
SELL
Bona fide gift
|
Direct |
2,632,721
-100.0%
|
-
|
Jun 10
2024
|
Trevor Bezdek Chairman |
SELL
Bona fide gift
|
Indirect |
2,632,721
-100.0%
|
-
|
Jun 10
2024
|
Douglas Joseph Hirsch Chief Mission Officer |
BUY
Bona fide gift
|
Indirect |
5,265,442
+50.0%
|
-
|
Jun 10
2024
|
Douglas Joseph Hirsch Chief Mission Officer |
SELL
Bona fide gift
|
Direct |
2,632,721
-100.0%
|
-
|
Jun 10
2024
|
Douglas Joseph Hirsch Chief Mission Officer |
SELL
Bona fide gift
|
Indirect |
2,632,721
-100.0%
|
-
|
Jun 08
2024
|
Scott Wagner Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35,776
-30.84%
|
$286,208
$8.55 P/Share
|
Jun 08
2024
|
Scott Wagner Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,591
+37.83%
|
-
|
Jun 08
2024
|
Romin Nabiey Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,437
-1.63%
|
$35,496
$8.55 P/Share
|
Jun 08
2024
|
Romin Nabiey Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,433
+4.3%
|
-
|
Jun 08
2024
|
Karsten Voermann Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,481
-8.08%
|
$171,848
$8.55 P/Share
|
Jun 08
2024
|
Karsten Voermann Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
54,064
+16.89%
|
-
|
Jun 07
2024
|
Trevor Bezdek Chairman |
BUY
Bona fide gift
|
Indirect |
2,632,721
+50.0%
|
-
|
Jun 07
2024
|
Trevor Bezdek Chairman |
SELL
Bona fide gift
|
Direct |
2,632,721
-50.0%
|
-
|
Jun 07
2024
|
Douglas Joseph Hirsch Chief Mission Officer |
BUY
Bona fide gift
|
Indirect |
2,632,721
+50.0%
|
-
|
Jun 07
2024
|
Douglas Joseph Hirsch Chief Mission Officer |
SELL
Bona fide gift
|
Direct |
2,632,721
-50.0%
|
-
|
Jun 06
2024
|
Julie Mb Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,398
+18.68%
|
-
|
Jun 06
2024
|
Agnes Rey Giraud Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,398
+21.92%
|
-
|
Jun 06
2024
|
Kelly J. Kennedy Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,398
+50.0%
|
-
|
Jun 01
2024
|
Trevor Bezdek Chairman |
BUY
Conversion of derivative security
|
Direct |
126,552
+2.35%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 164K shares |
---|---|
Exercise of conversion of derivative security | 739K shares |
Conversion of derivative security | 41.5M shares |
Bona fide gift | 15.8M shares |
Open market or private purchase | 183K shares |
Payment of exercise price or tax liability | 331K shares |
---|---|
Bona fide gift | 15.8M shares |
Sale (or disposition) back to the issuer | 32.9M shares |